EXHIBIT 31.1

                  CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
                       PURSUANT TO RULES 13a-14 AND 15d-14
                     OF THE SECURITIES EXCHANGE ACT OF 1934

I,  Raghunath  Kilambi,  Chief  Executive  Officer of Swiss  Medica,  Inc.  (the
"Company"), certify that:

      I have reviewed this quarterly report on Form 10-QSB of Swiss Medica, Inc.

      Based on my knowledge,  this quarterly  report does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not  misleading  with respect to the period covered by this quarterly
report.

      Based on my  knowledge,  the  financial  statements,  and other  financial
information included in the report,  fairly present in all material respects the
financial  condition,  results of operations and cash flows of the Company as of
September 30, 2005, and for the periods, presented in the report.

      I am responsible for establishing and maintaining  disclosure controls and
procedures  (as defined in Exchange Act Rules 13a-14 and 15d-14) for the Company
and have:

      (a)   designed such  disclosure  controls and  procedures,  or caused such
            disclosure   controls  and   procedures  to  be  designed  under  my
            supervision,  to ensure that  material  information  relating to the
            Company, including its consolidated  subsidiaries,  is made known to
            me by others within those entities,  particularly  during the period
            in which the periodic report is being prepared;

      (b)   evaluated the effectiveness of the Company's disclosure controls and
            procedures  and presented in this report our  conclusions  about the
            effectiveness of the disclosure  controls and procedures,  as of the
            end of the period  covered by this  quarterly  report  based on such
            evaluation; and

      (c)   disclosed  in this  quarterly  report  any  change in the  Company's
            internal  control over financial  reporting that occurred during the
            Company's most recent fiscal  quarter that has materially  affected,
            or is reasonably likely to materially affect, the Company's internal
            control over financial reporting; and

      I have disclosed,  based on our most recent evaluation of internal control
over financial  reporting,  to the Company's auditors and to the audit committee
of the board of directors (or persons fulfilling the equivalent function):

      (i)   all significant  deficiencies in the design or operation of internal
            control over  financial  reporting  which are  reasonably  likely to
            adversely affect the Company's ability to record, process, summarize
            and report financial information; and

      (ii)  any fraud,  whether or not  material,  that  involves  management or
            other  employees  who  have a  significant  role  in  the  Company's
            internal control over financial reporting.

Dated:  November 13, 2005


By: /s/ RAGHUNATH KILAMBI
------------------------------
Raghunath Kilambi,
Chief Executive Officer